Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; ... (2022). Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature, 609(7929), E13. Springer Nature 10.1038/s41586-022-05287-8

[img]
Preview
Text
s41586-022-05287-8.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (759kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Animal Pathology

UniBE Contributor:

Rottenberg, Sven

Subjects:

600 Technology > 630 Agriculture
600 Technology > 610 Medicine & health

ISSN:

1476-4687

Publisher:

Springer Nature

Language:

English

Submitter:

Pubmed Import

Date Deposited:

05 Sep 2022 13:05

Last Modified:

05 Dec 2022 16:23

Publisher DOI:

10.1038/s41586-022-05287-8

Related URLs:

PubMed ID:

36050473

BORIS DOI:

10.48350/172656

URI:

https://boris.unibe.ch/id/eprint/172656

Actions (login required)

Edit item Edit item
Provide Feedback